October 29, 2014: After a week of rumors, the other shoe dropped and Paris-based Sanofi fired chief executive Chris Viehbacher. Viehbacher had run the company since 2008, but butted heads with the board, although he was popular with investors.
October 29, 2014: The world’s third largest biotech, Amgen Inc, said Tuesday it will use the money it saves from cutting 20 percent of its workforce, or 4,000 jobs, to double down on research, new products and the rollout of its existing blockbuster drug pipeline.
October 29, 2014: Johnson & Johnson Innovation, an early-stage life sciences accelerator, announced today that it was opening its Asia Pacific Innovation Center, located in Shanghai. In addition to the China location, it will have satellites in Singapore, Australia and Japan.
October 30, 2014: Biosimilars could threaten some cherished and lucrative franchises—and a annual sales numbers for 2013 from Thomson Reuters underscore that risk...